Details of the Drug

General Information of Drug (ID: DMB2MKU)

Drug Name
CIGB-128
Synonyms HeberPAG; IFN alpha2b + IFN gamma (injectable, skin cancer), CIGB
Indication
Disease Entry ICD 11 Status REF
Basal cell carcinoma 2C32 Phase 1 [1]
Cross-matching ID
TTD ID
D06NDP

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interferon-alpha 2 (IFNA2) TTSIUJ9 IFNA2_HUMAN Modulator [2]
Interferon-gamma (IFNG) TT93WF5 IFNG_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037683)
2 Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG) in patients with mycosis fungoides: an open-label trial.BMC Pharmacol Toxicol.2012 Dec 28;13:20.